← Back to Search

Light Exposure and Sleep Scheduling for Teen Sleep Disorders

N/A
Waitlist Available
Led By Brant P Hasler, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Currently in 11th or 12th grade and enrolled in a traditional high-school; or cyber school with synchronous classes (not home-schooled)
Age 16-19 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during follow-ups after the manipulation through study completion, up to 5 years
Awards & highlights

Study Summary

This trial will study whether sleep disorders in adolescence are linked to an increased risk of substance abuse, and whether treatment can help.

Who is the study for?
This study is for teens aged 16-19, in their junior or senior year of high school (traditional or cyber but not home-schooled), who are physically and mentally healthy. Participants must have a late sleep schedule with weekend bedtimes at 1 AM or later, and can't be using drugs other than alcohol, cannabis, and nicotine.Check my eligibility
What is being tested?
The trial tests if increasing morning light exposure, reducing evening blue light exposure, monitoring sleep patterns along with mood and substance use, and regulating sleep schedules can reduce the risk of substance abuse linked to delayed sleep phase in adolescents.See study design
What are the potential side effects?
There may be minimal side effects from this behavioral intervention. However, changes in light exposure could potentially affect mood temporarily or disrupt usual sleeping patterns during the adjustment period.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a high school junior or senior in a traditional or online school with live classes.
Select...
I am between 16 and 19 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during follow-ups after the manipulation through study completion, up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and during follow-ups after the manipulation through study completion, up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Behavioral inhibition
Circadian alignment
Neural correlates of impulse control
+2 more
Secondary outcome measures
Cannabis use

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ManipulationExperimental Treatment4 Interventions
For ~2 weeks, participants will be asked to adhere to the following: Sleep scheduling--advance bedtime by 1.5 hours ( + sleep duration) Decrease evening blue light exposure via blue blocker goggles (2 h before bed) Increase morning bright light exposure via bright light goggles (30 m after rise) Monitor sleep, mood, and substance use via smartphone-based platform and wrist actigraph
Group II: ControlActive Control1 Intervention
For ~2 weeks, participants will asked to adhere to the following: - Monitor sleep, mood, and substance use via smartphone-based platform and wrist actigraph
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sleep scheduling
2009
Completed Phase 2
~70

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,722 Previous Clinical Trials
16,342,900 Total Patients Enrolled
1 Trials studying Delayed Sleep Phase Syndrome
100 Patients Enrolled for Delayed Sleep Phase Syndrome
National Institute on Drug Abuse (NIDA)NIH
2,468 Previous Clinical Trials
2,619,200 Total Patients Enrolled
1 Trials studying Delayed Sleep Phase Syndrome
100 Patients Enrolled for Delayed Sleep Phase Syndrome
Brant P Hasler, PhDPrincipal InvestigatorUniversity of Pittsburgh

Media Library

Monitor sleep, mood, and substance use Clinical Trial Eligibility Overview. Trial Name: NCT03806296 — N/A
Delayed Sleep Phase Syndrome Research Study Groups: Control, Manipulation
Delayed Sleep Phase Syndrome Clinical Trial 2023: Monitor sleep, mood, and substance use Highlights & Side Effects. Trial Name: NCT03806296 — N/A
Monitor sleep, mood, and substance use 2023 Treatment Timeline for Medical Study. Trial Name: NCT03806296 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial involve participants who are of legal age?

"As indicated in the trial's standards of entry, only individuals aged between 16 and 19 years old are allowed to take part."

Answered by AI

To what extent are people participating in this research project?

"Affirmative, clinicaltrials.gov indicates that the trial is actively seeking volunteers. This investigation was initially advertised on December 3rd 2018 and most recently updated on March 1st 2022 with a goal of recruiting 150 participants at one location."

Answered by AI

Who qualifies to join this trial?

"This experiment seeks 150 adolescents aged 16 to 19 with delayed sleep phase disorder. Specifically, eligible candidates must be in either 11th or 12th grade and enrolled at a traditional high school or cyber school providing synchronous classes (not home-schooled)."

Answered by AI

Are interested participants able to participate in this investigation now?

"According to clinicaltrials.gov, this study is currently accepting participants. It was initially launched on December 3rd 2018 and its information has been most recently updated on March 1st 2022."

Answered by AI
~23 spots leftby Apr 2025